The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Oncolytics Biotech Inc.’s current trading price is -5.70% away from its 52-week high, while its distance from the 52-week low is 168.05%. The stock’s price range for this period has been between $0.80 and $2.28 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 1.06 million for the day, a number notably higher than the average daily volume of 0.18 million over the last three months.
The present stock price for Oncolytics Biotech Inc. (ONCY) is $2.15. In the last trading session, the stock made a considerable jump, reaching $2.15 after an opening price of $1.80. The stock briefly fell to $1.80 before ending the session at $1.79.
25-cent Stock Takes $11T Commodities Sector Digital
One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.
All the details are in the FREE online report you can get here.
In terms of market performance, Oncolytics Biotech Inc. had a fairly even. The highest value for the stock in the past year was $2.28 on 12/01/22, and the lowest value was recorded at $0.80 on 06/14/22.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Oncolytics Biotech Inc. (ONCY) has experienced a quarterly rise of 32.72% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 127.15M and boasts a workforce of 29 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.5200, with a change in price of +0.5300. Similarly, Oncolytics Biotech Inc. recorded 202,382 in trading volume during the last 100 days, posting a change of +32.72%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for ONCY stands at 0.02. Similarly, the long-term debt-to-equity ratio is also 0.02.
ONCY Stock Stochastic Average
Oncolytics Biotech Inc.’s raw stochastic average for the past 50 days is presently 100.00%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 100.00%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 91.46% and 89.57%, respectively.
ONCY Stock Price Performance Analysis
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The index has shown a price gain of 31.90% this year. Over the last six months, there has been a weaker performance of 59.85%. The price of ONCY fallen by 90.27% during the last 30 days period. For the last 5-days stocks have improved 37.82%.